Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed | Zendy

Hong Li | Zendy; Tiankuo Yang | Zendy; Hong Tang | Zendy; Xiaoqiong Tang | Zendy; Yalin Shen | Zendy; Mohammed Benghezal | Zendy; Chin Yen Tay | Zendy; Barry J. Marshall | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed

Author(s) -

Hong Li,

Tiankuo Yang,

Hong Tang,

Xiaoqiong Tang,

Yalin Shen,

Mohammed Benghezal,

Chin Yen Tay,

Barry J. Marshall

Publication year - 2019

Publication title -

precision clinical medicine

Language(s) - English

Resource type - Journals

eISSN - 2096-5303

pISSN - 2516-1571

DOI - 10.1093/pcmedi/pbz009

Subject(s) - helicobacter pylori , helicobacter pylori infection , antibiotic resistance , empiric therapy , infectious disease (medical specialty) , antibiotics , antimicrobial stewardship , antimicrobial , medicine , disease , antibiotic therapy , immunology , intensive care medicine , microbiology and biotechnology , biology

Helicobacter pylori infection is an infectious disease. Given the alarmingly high antibiotic resistance in H. pylori, gastroenterologists should change the empiric H. pylori treatment paradigm to an antimicrobial susceptibility testing-guided precision treatment. Antimicrobial stewardship programs for H. pylori should be implemented locally, regionally, and nationally to monitor the antibiotic resistance pattern.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research